Novavax to Host Conference Call to Discuss Second Quarter 2024 Financial Results and Operational Highlights on August 8, 2024

Rhea-AI Summary

Novavax (Nasdaq: NVAX) has announced it will report its second quarter 2024 financial results and operational highlights on August 8, 2024 at 8:30 a.m. Eastern Time. The company, which focuses on advancing protein-based vaccines with its Matrix-M™ adjuvant, will host a conference call and webcast for this purpose. Participants can join via phone or webcast, with registration available through a provided URL. The call will be accessible domestically at (800) 836-8184 and internationally at (+1) (646) 357-8785. A replay will be available from 11:30 a.m. ET on August 8 until August 15, 2024, with the webcast replay extending to September 8, 2024.

News Market Reaction

-1.87%

1 alert

-1.87% News Effect

On the day this news was published, NVAX declined 1.87%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

GAITHERSBURG, Md., Aug. 1, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced it will report its second quarter 2024 financial results and operational highlights at 8:30 a.m. Eastern Time (ET) on Thursday, August 8, 2024. Details of the event and replay are as follows:

Conference call details:
Date:	August 8, 2024
Time:	8:30 a.m. U.S. ET
URL to register phone:	https://emportal.ink/3XTduSS
Dial-in number:	(800) 836-8184 (Domestic) or
	(+1) (646) 357-8785 (International)
Webcast:	ir.novavax.com/events

• Participants can join the conference call without operator assistance by registering and entering their phone number with the above URL to receive an instant automated call back.
• Participants can also dial direct to be entered into the call by an operator and will be prompted to request to join the Novavax, Inc. call.
• To ensure a timely connection, it is recommended that participants join at least 10 minutes prior to the scheduled webcast.

Replay details:
Date:	Available starting at 11:30 a.m. ET, August 8, 2024, until 11:59 p.m. U.S. ET, August 15, 2024
Dial-in number:	(888) 660-6345 (Domestic) or
	(+1) (646) 517-4150 (International)
Passcode:	52500#
Webcast:	ir.novavax.com/events, until September 8, 2024

About Novavax
Novavax, Inc. (Nasdaq: NVAX) promotes improved health by discovering, developing and commercializing innovative vaccines to help protect against serious infectious diseases. Novavax, a global company based in Gaithersburg, Md., U.S., offers a differentiated vaccine platform that combines a recombinant protein approach, innovative nanoparticle technology and Novavax's patented Matrix-M adjuvant to enhance the immune response. The Company's portfolio includes its COVID-19 vaccine and its pipeline includes COVID-19-Influenza Combination and stand-alone influenza vaccine candidates. In addition, Novavax's adjuvant is included in the University of Oxford and Serum Institute of India's R21/Matrix-M malaria vaccine. Please visit novavax.com and LinkedIn for more information.

Contacts:

Investors
Erika Schultz
240-268-2022
ir@novavax.com

Media
Giovanna Chandler
202-709-5563
media@novavax.com

 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/novavax-to-host-conference-call-to-discuss-second-quarter-2024-financial-results-and-operational-highlights-on-august-8-2024-302212235.html

SOURCE Novavax, Inc.

FAQ

When will Novavax (NVAX) report its Q2 2024 financial results?

Novavax (NVAX) will report its second quarter 2024 financial results and operational highlights on Thursday, August 8, 2024, at 8:30 a.m. Eastern Time.

How can investors join Novavax's (NVAX) Q2 2024 earnings call?

Investors can join Novavax's Q2 2024 earnings call by phone using the numbers (800) 836-8184 (Domestic) or (+1) (646) 357-8785 (International), or via webcast at ir.novavax.com/events. Registration is also available through a provided URL for automated callback.

Until when will the replay of Novavax's (NVAX) Q2 2024 earnings call be available?

The phone replay of Novavax's Q2 2024 earnings call will be available until August 15, 2024, while the webcast replay will be accessible until September 8, 2024.

What is the focus of Novavax's (NVAX) business?

Novavax (NVAX) is a global company advancing protein-based vaccines with its proprietary Matrix-M™ adjuvant technology.